163 related articles for article (PubMed ID: 36517838)
41. Circulating Trimethylamine-N-Oxide and Risk of All-Cause and Cardiovascular Mortality in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
Zhou Z; Jin H; Ju H; Sun M; Chen H; Li L
Front Med (Lausanne); 2022; 9():828343. PubMed ID: 35433743
[TBL] [Abstract][Full Text] [Related]
42. The correlation between plasma trimethylamine N-oxide level and heart failure classification in northern Chinese patients.
Dong Z; Liang Z; Wang X; Liu W; Zhao L; Wang S; Hai X; Yu K
Ann Palliat Med; 2020 Sep; 9(5):2862-2871. PubMed ID: 32921087
[TBL] [Abstract][Full Text] [Related]
43. Trimethylamine-N-oxide (TMAO) predicts short- and long-term mortality and poor neurological outcome in out-of-hospital cardiac arrest patients.
Hochstrasser SR; Metzger K; Vincent AM; Becker C; Keller AKJ; Beck K; Perrig S; Tisljar K; Sutter R; Schuetz P; Bernasconi L; Neyer P; Marsch S; Hunziker S
Clin Chem Lab Med; 2020 Aug; 59(2):393-402. PubMed ID: 32866111
[TBL] [Abstract][Full Text] [Related]
44. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
[No Abstract] [Full Text] [Related]
45. Association of trimethylamine
Zhang P; Zou JZ; Chen J; Tan X; Xiang FF; Shen B; Hu JC; Wang JL; Wang YQ; Yu JB; Nie YX; Chen XH; Yu JW; Zhang Z; Lv WL; Xie YQ; Cao XS; Ding XQ
Ren Fail; 2020 Nov; 42(1):1004-1014. PubMed ID: 32985309
[TBL] [Abstract][Full Text] [Related]
46. Higher Trimethylamine-
Rath S; Rox K; Kleine Bardenhorst S; Schminke U; Dörr M; Mayerle J; Frost F; Lerch MM; Karch A; Brönstrup M; Pieper DH; Vital M
mSystems; 2021 Oct; 6(5):e0094521. PubMed ID: 34519520
[TBL] [Abstract][Full Text] [Related]
47. Plasma trimethylamine N-oxide, a gut microbe-generated phosphatidylcholine metabolite, is associated with autism spectrum disorders.
Quan L; Yi J; Zhao Y; Zhang F; Shi XT; Feng Z; Miller HL
Neurotoxicology; 2020 Jan; 76():93-98. PubMed ID: 31704102
[TBL] [Abstract][Full Text] [Related]
48. Long-term survival in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Insights from a referral center in Portugal.
Santos M; Gomes A; Cruz C; Rocha J; Ricardo M; Gonçalves F; Carvalho L; Vicente M; Melo A; Reis A
Rev Port Cardiol (Engl Ed); 2018 Sep; 37(9):749-757. PubMed ID: 30144959
[TBL] [Abstract][Full Text] [Related]
49. High plasma levels of trimethylamine N-oxide are associated with poor outcome in intracerebral hemorrhage patients.
Zhai Q; Sun T; Sun C; Yan L; Wang X; Wang Y; Sun J; Zhao Y
Neurol Sci; 2021 Mar; 42(3):1009-1016. PubMed ID: 32705490
[TBL] [Abstract][Full Text] [Related]
50. Plasma markers in pulmonary hypertension subgroups correlate with patient survival.
Koudstaal T; van Uden D; van Hulst JAC; Heukels P; Bergen IM; Geenen LW; Baggen VJM; van den Bosch AE; van den Toorn LM; Chandoesing PP; Kool M; Boersma E; Hendriks RW; Boomars KA
Respir Res; 2021 May; 22(1):137. PubMed ID: 33947407
[TBL] [Abstract][Full Text] [Related]
51. Trimethylamine N-Oxide is Associated with Heart Failure Risk in Patients with Preserved Ejection Fraction.
Dong Z; Zheng S; Shen Z; Luo Y; Hai X
Lab Med; 2021 Jul; 52(4):346-351. PubMed ID: 33135738
[TBL] [Abstract][Full Text] [Related]
52. Plasma copeptin levels in children with pulmonary arterial hypertension associated with congenital heart disease.
Gaheen R; El Amrousy D; Hodeib H; Elnemr S
Eur J Pediatr; 2021 Sep; 180(9):2889-2895. PubMed ID: 33813676
[TBL] [Abstract][Full Text] [Related]
53. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P
PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065
[TBL] [Abstract][Full Text] [Related]
54. High Betaine and Dynamic Increase of Betaine Levels Are Both Associated With Poor Prognosis of Patients With Pulmonary Hypertension.
Yang Y; Xu J; Zhou J; Xue J; Gao J; Li X; Sun B; Yang B; Liu Z; Zhao Z; Luo Q; Zeng Q; Zheng L; Xiong C
Front Cardiovasc Med; 2022; 9():852009. PubMed ID: 35433890
[TBL] [Abstract][Full Text] [Related]
55. PCOS without hyperandrogenism is associated with higher plasma Trimethylamine N-oxide levels.
Huang J; Liu L; Chen C; Gao Y
BMC Endocr Disord; 2020 Jan; 20(1):3. PubMed ID: 31906930
[TBL] [Abstract][Full Text] [Related]
56. Trimethylamine-N-oxide has prognostic value in coronary heart disease: a meta-analysis and dose-response analysis.
Yao ME; Liao PD; Zhao XJ; Wang L
BMC Cardiovasc Disord; 2020 Jan; 20(1):7. PubMed ID: 31918665
[TBL] [Abstract][Full Text] [Related]
57. Gut microbiota-generated metabolite, trimethylamine-N-oxide, and subclinical myocardial damage: a multicenter study from Thailand.
Senthong V; Kiatchoosakun S; Wongvipaporn C; Phetcharaburanin J; Tatsanavivat P; Sritara P; Phrommintikul A
Sci Rep; 2021 Jul; 11(1):14963. PubMed ID: 34294762
[TBL] [Abstract][Full Text] [Related]
58. Paradox of trimethylamine-N-oxide, the impact of malnutrition on microbiota-derived metabolites and septic patients.
Chou RH; Wu PS; Wang SC; Wu CH; Lu SF; Lien RY; Tsai YL; Lu YW; Kuo MR; Guo JY; Chou RY; Huang PH; Lin SJ
J Intensive Care; 2021 Oct; 9(1):65. PubMed ID: 34674768
[TBL] [Abstract][Full Text] [Related]
59. Trimethylamine-N-oxide (TMAO) and clinical outcomes in patients with end-stage kidney disease receiving peritoneal dialysis.
Chang D; Xu X; Yang Z; Ma T; Nie J; Dong J
Perit Dial Int; 2022 Nov; 42(6):622-630. PubMed ID: 34724845
[TBL] [Abstract][Full Text] [Related]
60. Relationship between elevated plasma trimethylamine N-oxide levels and increased stroke injury.
Wu C; Xue F; Lian Y; Zhang J; Wu D; Xie N; Chang W; Chen F; Wang L; Wei W; Yang K; Zhao W; Wu L; Song H; Ma Q; Ji X
Neurology; 2020 Feb; 94(7):e667-e677. PubMed ID: 31907287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
